APA (7th ed.) Citation

Pin, S., Bidlack, J., Knapp, B., Deaver, D., Plotnikava, M., Arnelle, D., . . . Namchuk, M. (2019). In vitro characterization of buprenorphine, samidorphan, and combinations being developed as an adjunctive treatment for major depressive disorder. European Neuropsychopharmacology, 29, S546. https://doi.org/10.1016/j.euroneuro.2018.11.807

Chicago Style (17th ed.) Citation

Pin, S., J. Bidlack, B. Knapp, D. Deaver, M. Plotnikava, D. Arnelle, A. Quinn, M. Toh, and M. Namchuk. "In Vitro Characterization of Buprenorphine, Samidorphan, and Combinations Being Developed as an Adjunctive Treatment for Major Depressive Disorder." European Neuropsychopharmacology 29 (2019): S546. https://doi.org/10.1016/j.euroneuro.2018.11.807.

MLA (9th ed.) Citation

Pin, S., et al. "In Vitro Characterization of Buprenorphine, Samidorphan, and Combinations Being Developed as an Adjunctive Treatment for Major Depressive Disorder." European Neuropsychopharmacology, vol. 29, 2019, p. S546, https://doi.org/10.1016/j.euroneuro.2018.11.807.